Title: Logo
1 2Adverse Event Reporting And Pharmaceutical
Marketing Research
3Adverse Event Reporting And You!!!
4Market Researchers Are Not Equipped To Assume
The Responsibility Or Liability Associated
With Adverse Event Reporting-And May Not
Understand The Risk
5CASRO Taskforce, Pharma Market Research
Report- January/February, 2006
6Major Survey Research Trade Organization
Cautions On Dangers Of Using Pharmaceutical
Surveys As A Component Of Pharmacovigilence
Process
7CASRO Press Release June 28, 2006
8True Today-But Needs To Change Significantly
And Quickly
9(No Transcript)
10(No Transcript)
11Principles You Need To Follow
12Make A High Level Spokesperson Available
13Accept Responsibility/ Express Compassion
14You Cant Put The Genie Back In The Bottle
15The Bank Of Goodwill
16Important Issues Include
17An Adverse Event Is...?
18An Adverse Drug Reaction?
19Lack Of Efficacy?
20Need To Titrate?
21All Of The Above?
22Current/Potential Impacts
- Less Pharmaceutical Marketing Research Being
Conducted - Significant Increases In Research Costs/Timing
- Biases Resulting By Avoiding AE-Evoking Questions
- Increased Recruiting Challenges
23We Need To
- Agree On A Practical Definition Of An Adverse
Event - Understand That Cause And Effect Are Not For The
Marketing Research Agency To Determine - Work Together To Develop Standard Reporting
Policies, Mechanisms, Etc.
24We Can
- Provide Routine Guidance To Contact
Physician or MedWatch - Report The Event Without Patient
Identification/Contact Information - Request Patient Permission To Report
Identification/Contact Information If Adverse
Event Is Discussed - Notify Respondents That If An Adverse Event Is
Discussed, They May Be Contacted
25Training
- Pharmaceutical Company Provides Slides For
Marketing Research Agency To Use In-House - In-House Training Provided At Marketing Research
Agency, Or At Company, By A Pharmaceutical
Company Employee - On-Line Training Provided By Pharmaceutical
Company
26Pharmaceutical Marketing Research Agencies Must
27Develop Their Own Policies And Procedures For
Dealing With Adverse Events
28And Use Them To Support, Not
ToThwart, Our ClientsCompliance Efforts
29